Ask AI
ProCE Banner Activity

Improving Outcomes for Patients With Advanced NSCLC Through the Optimal Integration of HER2-Targeted Antibody–Drug Conjugate Therapy

Slideset

Downloadable slides with a comprehensive review of the optimal utilization of HER2-targeted treatment strategies for patients with advanced NSCLC from a live event.

Released: October 25, 2023

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.